Stockreport

UroGen Announces New Data Presentations at the Society of Urologic Oncology 2024 Annual Meeting Highlighting Urothelial Cancer Portfolio Aimed at Addressing Unmet Needs [Yahoo! Finance]

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF The data highlights the potential of UGN-102 in treating low-grade, intermediate-risk non-muscle-invasive bladder cancer and the ongoing clinical value of JELMYTO for tr [Read more]